Beta Pharma, Inc. is an emerging specialty pharmaceutical company dedicated to the discovery, development, and commercialization of innovative late stage therapies targeting oncology. Our product pipeline is diverse and undergoing rapid development.
Beta Pharma, Inc. was founded at the Science Park Campus of Yale in 1996 as a contract research organization (CRO) providing custom synthesis services to biotechnology and pharmaceutical companies. Profits from the CRO business helped to fund the fledgling company’s new drug discovery projects, which soon found success in oncology drugs. Since then, Beta Pharma has developed into its own independent pharmaceutical company that focuses on the research, development, and commercialization of innovative new chemical entity (NCE) drugs for oncology. Beta Pharma strives to provide better medicine at an affordable price, to our patients for a better quality of life.